Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Neuronetics Inc (NASDAQ: STIM) closed at $3.1 up 0.32% from its previous closing price of $3.09. In other words, the price has increased by $0.32 from its previous closing price. On the day, 0.7 million shares were traded. STIM stock price reached its highest trading level at $3.135 during the session, while it also had its lowest trading level at $3.025.
Ratios:
For a deeper understanding of Neuronetics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.84 and its Current Ratio is at 2.02. In the meantime, Its Debt-to-Equity ratio is 2.97 whereas as Long-Term Debt/Eq ratio is at 2.77.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 08 ’25 when Madryn Asset Management, LP sold 3,500,000 shares for $3.72 per share. The transaction valued at 13,020,000 led to the insider holds 1,142,351 shares of the business.
MADRYN HEALTH PRTS II (CAY MAS bought 2,925,554 shares of STIM for $10,883,061 on Aug 08 ’25. On Aug 08 ’25, another insider, MADRYN HEALTH PARTNERS II, LP, who serves as the 10% Owner of the company, bought 192,806 shares for $3.72 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, STIM now has a Market Capitalization of 204986928 and an Enterprise Value of 279034944. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.84 while its Price-to-Book (P/B) ratio in mrq is 7.55. Its current Enterprise Value per Revenue stands at 2.511 whereas that against EBITDA is -7.975.
Stock Price History:
The Beta on a monthly basis for STIM is 1.19, which has changed by 1.8878505 over the last 52 weeks, in comparison to a change of 0.18258524 over the same period for the S&P500. Over the past 52 weeks, STIM has reached a high of $5.92, while it has fallen to a 52-week low of $0.52. The 50-Day Moving Average of the stock is 2.44%, while the 200-Day Moving Average is calculated to be -16.17%.
Shares Statistics:
For the past three months, STIM has traded an average of 1.34M shares per day and 1136790 over the past ten days. A total of 66.11M shares are outstanding, with a floating share count of 40.37M. Insiders hold about 38.94% of the company’s shares, while institutions hold 27.58% stake in the company. Shares short for STIM as of 1760486400 were 5807649 with a Short Ratio of 4.34, compared to 1757894400 on 6122194. Therefore, it implies a Short% of Shares Outstanding of 5807649 and a Short% of Float of 15.55.
Earnings Estimates
A comprehensive evaluation of Neuronetics Inc (STIM) is underway, with the input of 2.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.09 and low estimates of -$0.09.
Analysts are recommending an EPS of between -$0.56 and -$0.57 for the fiscal current year, implying an average EPS of -$0.56. EPS for the following year is -$0.47, with 2.0 analysts recommending between -$0.44 and -$0.49.
Revenue Estimates
A total of 3 analysts believe the company’s revenue will be $37.85M this quarter.It ranges from a high estimate of $38.14M to a low estimate of $37.4M. As of. The current estimate, Neuronetics Inc’s year-ago sales were $18.53MFor the next quarter, 3 analysts are estimating revenue of $43.06M. There is a high estimate of $43.8M for the next quarter, whereas the lowest estimate is $42.37M.
A total of 3 analysts have provided revenue estimates for STIM’s current fiscal year. The highest revenue estimate was $151.3M, while the lowest revenue estimate was $150.79M, resulting in an average revenue estimate of $151.03M. In the same quarter a year ago, actual revenue was $74.5MBased on 3 analysts’ estimates, the company’s revenue will be $168.8M in the next fiscal year. The high estimate is $173.4M and the low estimate is $166.01M.
